S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:IMMU

Immunomedics Short Interest Ratio and Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.
$87.86
0.00 (0.00 %)
(As of 10/23/2020)
Add
Compare
Today's Range
$87.86
Now: $87.86
$87.86
50-Day Range
$85.08
MA: $87.41
$87.86
52-Week Range
$8.80
Now: $87.86
$87.93
VolumeN/A
Average Volume4.01 million shs
Market Capitalization$20.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.9

Short Interest

Immunomedics (NASDAQ:IMMU) Short Interest Data

Current Short Volume:23,600,000 shares
Previous Short Volume:26,650,000 shares
Change Vs. Previous Month:-11.44%
Dollar Volume Sold Short:$2.04 billion
Short Interest Ratio / Days to Cover:0.0
Last Record Date:September, 30 2020
Outstanding Shares:191,540,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:0 shares
Average Trading Volume:4,013,131 shares
Today's Volume Vs. Average:-100.00%



Immunomedics (NASDAQ:IMMU) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/30/202023,600,000 $2.04 billion -11.4%0.0%0$86.53
9/15/202026,650,000 $2.27 billion 2.4%0.0%6.1$85.36
8/31/202026,030,000 $1.10 billion -1.0%0.0%10.1$42.24
8/14/202026,290,000 $1.16 billion -0.7%0.0%9.4$44.20
7/31/202026,470,000 $1.10 billion -1.5%0.0%8.7$41.70
7/15/202026,870,000 $1.13 billion 1.6%0.0%6.5$42.23
6/30/202026,440,000 $1.09 billion -10.2%0.0%5.9$41.21
6/15/202029,430,000 $1.09 billion 1.8%0.0%5.8$36.98
5/29/202028,920,000 $1.01 billion -1.1%0.0%5.6$34.92
5/15/202029,240,000 $982.17 million 3.5%0.0%5.8$33.59
4/30/202028,260,000 $965.64 million -10.3%0.0%6$34.17
4/15/202031,490,000 $1.04 billion 8.0%0.0%7.7$32.89
3/31/202029,150,000 $829.03 million 9.1%0.0%8.7$28.44
3/13/202026,724,800 $524.88 million -1.4%0.0%12.6$19.64
2/28/202027,090,000 $303.68 million -0.7%0.0%13.7$11.21
2/14/202027,270,000 $416.14 million 0.2%0.0%13$15.26
1/31/202027,220,000 $445.59 million 2.5%0.0%12.8$16.37
1/15/202026,550,000 $508.43 million 5.3%0.0%12$19.15
12/31/201925,220,000 $461.02 million -2.4%0.0%11.6$18.28
11/15/201929,940,000 $563.17 million -5.5%16.5%13.5$18.81

Immunomedics (NASDAQ:IMMU) Short Interest FAQ

speech bubbles
speech bubbles











What is Immunomedics' current short interest?

Short interest is the volume of Immunomedics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 23,600,000 shares of IMMU short. 0.00% of Immunomedics' shares are currently sold short. View details.

Is Immunomedics' short interest increasing or decreasing?

Immunomedics saw a drop in short interest in September. As of September 30th, there was short interest totaling 23,600,000 shares, a drop of 11.4% from the previous total of 26,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Immunomedics' short interest compare to its competitors?

0.00% of Immunomedics' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Immunomedics: Amgen Inc. (1.05%), Gilead Sciences, Inc. (1.55%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals, Inc. (2.02%), Biogen Inc. (1.79%), Seagen Inc. (0.00%), Alexion Pharmaceuticals, Inc. (2.56%), Exact Sciences Co. (0.00%), Incyte Co. (0.00%), and Alnylam Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.12 billion), Aon Plc ($3.76 billion), The Clorox Company ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog, Inc. ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), The Kroger Co. ($2.20 billion), and Simon Property Group, Inc. ($1.88 billion). View all of the most shorted stocks.

What does it mean to sell short Immunomedics stock?

Short selling IMMU is an investing strategy that aims to generate trading profit from Immunomedics as its price is falling. To short Immunomedics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Immunomedics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunomedics?

A short squeeze for Immunomedics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMMU, which in turn drives the price of the stock up even further.

How often is Immunomedics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMMU, twice per month. The most recent reporting period available is September, 30 2020.


This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.